Document Detail


Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levels.
MedLine Citation:
PMID:  7845006     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The bcr-abl oncogene is a fusion gene resulting from a reciprocal translocation which forms the hallmark of chronic myeloid leukemia (CML). Antisense oligonucleotides complementary to the two possible mRNA breakpoints were found to inhibit cell growth of CML patient cells and cell lines, but doubt exists about their specificity. In order to test the specificity, phosphorothioate and 3' phosphorothioate capped antisense BCR-ABL oligonucleotides of different length were used. Stability, cellular uptake of oligonucleotides and effect on cell growth were studied in two CML cell lines, BV173 and LAMA-84. Phosphorothioate antisense BCR-ABL oligonucleotides were most stable, showed the highest uptake and induced cell death in BV173 but not in LAMA-84 cells. We selected the most effective antisense oligonucleotide for further analysis. The BV173 and LAMA-84 cell lines do not express the normal c-abl protein, we therefore used a c-abl specific monoclonal antibody for the detection of p210bcr-abl expression by flow cytometry. Dead cells found after treatment were gated out of analysis. Although BCR-ABL antisense oligonucleotides can induce apoptosis, no reduction of p210bcr-abl levels could be detected in living cells after treatment with antisense oligonucleotides. We conclude that antisense mediated inhibition of translation of mRNA into p210bcr-abl is not the mechanism responsible for the induction of apoptosis in cell line BV173.
Authors:
T F Smetsers; L T van de Locht; A H Pennings; H M Wessels; T M de Witte; E J Mensink
Related Documents :
7977636 - Small cell carcinomas of the lung express the bcl-2 protein.
8782646 - Down-regulation of apoptosis-related bcl-2 but not bcl-xl or bax proteins in multidrug-...
17342386 - Down-regulation of pge2 by physiologic levels of celecoxib is not sufficient to induce ...
8710376 - Repression of apoptosis in human b-lymphoma cells by cd40-ligand and bcl-2: relationshi...
16951566 - Muller glia induce retinal progenitor cells to differentiate into retinal ganglion cells.
18585786 - Discrimination of cell types in mixed cortical culture using calcium imaging: a compari...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Leukemia     Volume:  9     ISSN:  0887-6924     ISO Abbreviation:  Leukemia     Publication Date:  1995 Jan 
Date Detail:
Created Date:  1995-03-06     Completed Date:  1995-03-06     Revised Date:  2013-03-04    
Medline Journal Info:
Nlm Unique ID:  8704895     Medline TA:  Leukemia     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  118-30     Citation Subset:  IM    
Affiliation:
Division of Hematology, University Hospital St. Radboud, Nijmegen, The Netherlands.
Data Bank Information
Bank Name/Acc. No.:
GENBANK/M17310;  M17986;  M17987;  X16416;  Y00661
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apoptosis / drug effects*
Base Sequence
Cell Division / drug effects
Fusion Proteins, bcr-abl / analysis*,  genetics,  physiology
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism*,  pathology
Molecular Sequence Data
Oligonucleotides, Antisense / pharmacology*
Proto-Oncogene Proteins c-abl / genetics
RNA, Messenger / analysis
Thionucleotides / pharmacology*
Tumor Cells, Cultured
Chemical
Reg. No./Substance:
0/Fusion Proteins, bcr-abl; 0/Oligonucleotides, Antisense; 0/RNA, Messenger; 0/Thionucleotides; EC 2.7.10.2/Proto-Oncogene Proteins c-abl

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia...
Next Document:  Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity ...